BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...
Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based ...
PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® portfolio of solutions, is pleased to announce that the “American Association of Clinical ...
BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results